Your browser doesn't support javascript.
A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan.
Pan, Sung-Ching; Huang, Yu-Shan; Hsieh, Szu-Min; Chen, Yee-Chun; Chang, Sui-Yuan; Chang, Shan-Chwen.
  • Pan SC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; The Center for Infection Control, National Taiwan University Hospital, Taipei, Taiwan.
  • Huang YS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Hsieh SM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Chen YC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; The Center for Infection Control, National Taiwan University Hospital, Taipei, Taiwan.
  • Chang SY; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Medical Technology, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: sychang@ntu.edu.tw.
  • Chang SC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: changsc@ntu.edu.tw.
J Formos Med Assoc ; 120(7): 1459-1463, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1014623
ABSTRACT

BACKGROUND:

Healthcare workers (HCWs) are at the frontline during the pandemic of COVID-19 globally. According to the WHO situation report at April 17, there were 22, 073 HCWs contracted the infection. Whether the infection control policy and practice in the hospital setting can protect the HCWs is an important issue.

METHODS:

We performed a cross-sectional serology study in a tertiary care hospital in Taiwan to explore the sero-prevalence rate among HCWs. The participants are enrolled on a voluntary basis. A structured questionnaire was collected to gather the epidemiology character and risk factors for potential exposure. ELISA tests as Architect SARS-CoV-2 IgG (Abbott) and Elecsys Anti-SARS-CoV-2 assay (Roche) were used to detect antibody responses. If any of the tests was positive, a western blot assay was used for confirmation.

RESULTS:

There were 194 HCWs participated during July 1 to Aug. 31, 2020. The mean age was 36.3 ± 10.4. More than half of the participants had possible hospital associated risk for COVID-19 exposure (110/192, 57.3%) and 64 had possible community risk for COVID-19 exposure (64/194, 33.0%). There was only one participant had positive test by Architect IgG test and confirmed to be negative for seasonal coronavirus and SARS-CoV-2 antibody. (Mikrogen Diagnostik, Germany).

CONCLUSION:

The cross-sectional serology study in a tertiary care hospital in Taiwan revealed no HCWs had positive serology response to SARS-CoV-2. We believe that the infection control policy and practice in the hospital and in the community are both important to prevent the disease transmission.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Personnel / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Adult / Humans / Middle aged Country/Region as subject: Asia Language: English Journal: J Formos Med Assoc Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: J.jfma.2021.01.002

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Personnel / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Adult / Humans / Middle aged Country/Region as subject: Asia Language: English Journal: J Formos Med Assoc Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: J.jfma.2021.01.002